Challenges for the development of bone-forming agents in Europe

Challenges for the development of bone-forming agents in Europe

Show other versions (1)

Bibliographic Details
Main Authors:	Kanis, J, Rizzoli, R, Cooper, C, Reginster, J
Format:	Journal article
Language:	English
Published:	Springer New York LLC 2014

Similar Items

Challenges for the development of bone-forming agents in Europe.
by: Kanis, J, et al.
Published: (2014)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
by: Kanis, J, et al.
Published: (2011)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
by: Kanis, J, et al.
Published: (2008)

The International Osteoporosis Foundation: history, objectives and achievements.
by: Cooper, C, et al.
Published: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
by: Cooper, C, et al.
Published: (2009)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
by: Cooper, C, et al.
Published: (2012)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
by: Rizzoli, R, et al.
Published: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
by: Rizzoli, R, et al.
Published: (2011)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
by: Kanis, J, et al.
Published: (2008)

A reappraisal of generic bisphosphonates in osteoporosis.
by: Kanis, J, et al.
Published: (2012)

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Bruyère, O, et al.
Published: (2014)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
by: Delmas, P, et al.
Published: (2005)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
by: Rizzoli, R, et al.
Published: (2011)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Rizzoli, R, et al.
Published: (2013)

Recommendations for bone marker standards in osteoporosis: what, why and where to now?
by: Vasikaran, S, et al.
Published: (2011)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
by: Rizzoli, R, et al.
Published: (2014)

Standardising biochemical assessment of bone turnover in osteoporosis.
by: Vasikaran, S, et al.
Published: (2011)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
by: Bruyère, O, et al.
Published: (2008)

Relationship between low bone mineral density and fractures with incident cardiovascular disease: a systematic review and meta-analysis
by: Veronese, N, et al.
Published: (2017)

Management of glucocorticoid-induced osteoporosis.
by: Rizzoli, R, et al.
Published: (2012)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
by: Kanis, J, et al.
Published: (1997)

Agents, Challenges, Visions and Consequences of National Museum Making in Europe
by: Peter Aronsson
Published: (2012-07-01)

How to define responders in osteoarthritis.
by: Cooper, C, et al.
Published: (2013)

The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
by: Kanis, J, et al.
Published: (1977)

Antidepressant medications and osteoporosis
by: Rizzoli, R, et al.
Published: (2012)

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
by: Vasikaran, S, et al.
Published: (2011)

Frailty and sarcopenia: definitions and outcome parameters
by: Cooper, C, et al.
Published: (2012)

Histological measurements in Paget's disease of bone.
by: Walton, R, et al.
Published: (1977)

Treatment of osteoporosis in men.
by: Kaufman, J, et al.
Published: (2013)

A meta-analysis of reference markers of bone turnover for prediction of fracture
by: Johansson, H, et al.
Published: (2014)

The development of a European questionnaire for quality of life in patients with vertebral osteoporosis.
by: Lips, P, et al.
Published: (1996)

Rural Development. Challenges and opportunities for Europe
by: Spaziante Agata
Published: (2014-03-01)

Tools in the assessment of sarcopenia.
by: Cooper, C, et al.
Published: (2013)

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
by: Walton, R, et al.
Published: (1975)

KAL'TsIY I VITAMIN D V VEDENIIOSTEOPOROZA
by: R RIZZOLI, et al.
Published: (2007-08-01)

A meta-analysis of reference markers of bone turnover for prediction of fracture.
by: Johansson, H, et al.
Published: (2014)

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
by: van Staal, T, et al.
Published: (2003)

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
by: van Staa, T, et al.
Published: (2003)